The aim of the Education Committee (EC) is to coordinate ESOT’s efforts to advance multidisciplinary education for transplant professionals at all career levels and to contribute to their professional development.
The Basic Science Committee promotes scientific issues and transplantation research within ESOT. An active basic science community and an efficient translation of innovation into the clinic are crucial for the future of transplantation medicine.
The European Transplant Allied Healthcare Professionals (ETAHP) reaches out to allied healthcare professionals throughout Europe in order to ensure the best care possible for all transplant patients, with the aim to optimize patient outcomes.
The Young Professionals in Transplantation (YPT) is the Network for Junior Transplant professionals of ESOT, representing all young transplant clinicians and scientists who are beginning a career in transplantation and organ donation.
The mission of ECTORS is to provide a forum for discussing and stimulating novel developments in the fields of cellular therapies in organ transplantation, organ regeneration and generation of new organs from stem cells and biomaterials.
ECTTA is the forum for experience exchange on treatment of patients with end-stage heart and lung failure. Our aim is to improve outcomes for the patients.
EDTCO aims to support health care professionals to provide clinically effective programmes on organ and tissue donation, procurement and transplantation.
EKITA is the Organ Expert Section of ESOT on kidney transplantation in Europe, providing a forum for kidney transplantation professionals to exchange scientific information and views aimed at providing the best service to European patients .
The European Liver and Intestine Transplant Association (ELITA), previously known as the European Liver Transplant Association (ELTA), is a section of ESOT. Its membership represents the expertise on liver and intestinal transplantation in Europe.
ELPAT is a European platform that brings continuity and progress in European research and dialogue on "Ethical, Legal and Psychosocial Aspects of organ Transplantation". ELPAT currently consists of over 160 experts from more than 25 European countries.
EPITA is established to provide a forum for those working in the field of pancreas and islet of Langerhans transplantation or any other alternative form of beta cell replacement in Europe, to exchange scientific information and views related primarily to providing the best service for patients in Europe requiring pancreas or islet transplantation.
VCA has opened a new era in the field of transplantation, reconstructive and restorative surgery. This Section brings together 10 representatives of major European teams at the forefront in this field.
We would like to say a big thank you to everyone who joined us at ESOT TLJ 3.0 and supported us on our mission to transform the world of transplantation. Experts convened from across the globe to shape the future clinical pathway of transplantation for 9 major topics and came up with 21 recommendations to
We are delighted to announce that the deadline to apply as an ETAHP board member has been extended: the new deadline is 4 December 2022. All ESOT/ETAHP affiliates are welcome to send nominations for these positions. In addition, you may nominate yourself or a colleague. The new ETAHP Board Members will hold office for four
EPITA encourages applications from either diabetes physicians or nephrologists with an interest in Beta Cell Replacement Therapy or transplant surgeons.
NEWLY PUBLISHED: 𝗘𝗦𝗢𝗧 𝗖𝗼𝗻𝘀𝗲𝗻𝘀𝘂𝘀 𝗣𝗹𝗮𝘁𝗳𝗼𝗿𝗺 𝗳𝗼𝗿 𝗢𝗿𝗴𝗮𝗻 𝗧𝗿𝗮𝗻𝘀𝗽𝗹𝗮𝗻𝘁𝗮𝘁𝗶𝗼𝗻: 𝗦𝗲𝘁𝘁𝗶𝗻𝗴 𝘁𝗵𝗲 𝗦𝘁𝗮𝗴𝗲 𝗳𝗼𝗿 𝗮 𝗥𝗶𝗴𝗼𝗿𝗼𝘂𝘀, 𝗥𝗲𝗴𝘂𝗹𝗮𝗿𝗹𝘆 𝗨𝗽𝗱𝗮𝘁𝗲𝗱 𝗗𝗲𝘃𝗲𝗹𝗼𝗽𝗺𝗲𝗻𝘁 𝗣𝗿𝗼𝗰𝗲𝘀𝘀
This series will provide expert advice and practical tips to support the personal and professional development of transplant professionals at all career stages. The topics of this series were selected based on the results of an educational needs assessment recently conducted by ESOT.
The European Foundation for the Study of Chronic Liver Failure (EF CLIF) is a private non-profit organization connecting biomedical researchers and healthcare professionals with each other, with patients and patient associations, and with society. The fundamental purpose of EF CLIF, reflected in its founding Statements of 2015, is to advance knowledge and promote research and
ESOT would like to share two recent transplant-related announcements made by the EMA. EMA consultation: iBox Scoring System in kidney transplant patients The EMA has published for public consultation a “draft qualification opinion for the iBox Scoring System as a secondary efficacy endpoint in clinical trials investigating novel immunosuppressive medicines in kidney transplant patients”.
The European Transplant Allied Healthcare Professionals (ETAHP) – would like to announce a call for nominations for two new Board members. All ESOT/ETAHP affiliates are welcome to send nominations for these positions. You may nominate yourself or a colleague. The new ETAHP Board Members will hold office for 4 years (2022-2026), starting December 2022. In
Do you want to learn more on the ESOT Mentorship Programme before applying either as mentors or mentees? Do you have any doubts on this new opportunity for professional development? Join us at the Info Session on Tuesday 18 October at 18:30 CEST! Luca Toti, Chair of the Education Committee, and Liset Pengel, Vice-Chair, will
CareDx has developed AlloSeq cfDNA, a targeted NGS assay that relies on 202 single-nucleotide polymorphisms (SNPs) located throughout the genome to measure the dd-cfDNA in transplant recipients. The assay was designed to be fully compatible with any clinical laboratory setup and combines a streamlined workflow with a fully automated analysis software to accurately quantify dd-cfDNA in transplant recipients.
